On June 23, 2021, the Department for Registration and Land Cadastre of the Kordai district of the branch of the non-profit joint-stock company “State Corporation “Government for Citizens” in the Zhambyl region” registered the OtarBioPharm Limited Liability Partnership.

The company was established during the Covid-19 coronavirus infection pandemic to produce immunobiological preparations (vaccines) against especially dangerous infectious diseases, including QazVac, coronavirus infection vaccine, according to the international standard of good manufacturing practice (GMP). Currently, the company provides bottling and storage services for biological products.
After the launch of the plant for the production of the active substance (approximately in August 2023) and reaching full capacity, the OtarBioPharm Biopharmaceutical Plant will be the first large full-cycle plant in the Republic of Kazakhstan for the production of immunobiological preparations (vaccines) against especially dangerous infectious diseases, including QazVac, the coronavirus infection vaccine, according to the international standard of good manufacturing practice (GMP),.